ACE Inhibitors in the Prevention and Therapy of Diabetic Nephropathy

Anderson AR, Christiansen JS, Anderson JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983 Anderson S, Brenner BM. Therapeutic benefit of converting-enzyme inhibitors in progressive renal disease. American Journal of Hypertension 1 (Suppl.): 380–383, 1988 Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting-enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation 77: 1993–2000, 1986 Baba T, Murabayashmi S, Takebe K. Comparison of the renal effect of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia 32: 40–44, 1989 Berglund G, Andersson O. β-Blockers or diuretics in hypertension?A 6-year follow-up of blood pressure and metabolic side effects. Lancet 1: 744–746, 1981 Berkin KE, Ball SG. Cough and angiotensin converting enzyme inhibition. British Medical Journal 296: 1279, 1988 Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. British Medical Journal 293: 471–474, 1986 Davies RO, Irvin JD, Kramsch DK, Walker JF, Moncloa F. Enalapril, worldwide experience. American Journal of Medicine 77: 23–25, 1984 De Venuto G, Andreotti C, Mattarei M, Pegoretti G. Long-term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no sign of renal impairment. Journal of Hypertension 3 (Suppl. 2): 143–145, 1985 Dunn BR, Zatz R, Rennke HG, Meyer TW, Anderson S, et al. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury. Journal of Hypertension 4 (Suppl. 5): 251–254, 1986 Elving L, De Nobel E, Vant Laar A. Effect of captopril on diabetic proteinuria. Correspondence. New England Journal of Medicine 315: 515–516, 1986 Feig PU, Rutan GH. Angiotensin converting enzyme inhibitors: the end of end stage renal disease. Annals of Internal Medicine 111: 451–452, 1989 Feldt-Rasmussen B, Mathiesen ER, Hegedus L, Deckert T. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. New England Journal of Medicine 314: 665–671, 1986 Fernere M, Lachkar H, Richard JL, Bringer J, Orsetti A, et al. Captopril and insulin sensitivity. Annals of Internal Medicine 102: 134–135, 1985 Ferriss JB, O’Hare JA, Kelleher CC, Sullivan PA, Cole M. Diabetic control, the renin angiotensin system, catecholamines and blood pressure. Hypertension 7 (Suppl. II): 58–63, 1985 Frohlich ED, Cooper RA, Lewis EJ. Review of the overall experience of captopril in hypertension. Archives of Internal Medicine 144: 1441–1444, 1984 Gambaro G, Morbiato F, Cicerello E, Del Turco M, Sartori L. Captopril in the treatment of hypertension in type I and type II diabetic patients. Journal of Hypertension (Suppl. 2): 149–151, 1985 Groel JT, Tadross SS, Dreslinski GR, et al. Long-term antihypertensive therapy with captopril. Hypertension 5: III 145–151, 1984 Hay U, Ludvik B, Gisinger CH, Schernthaner G. Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy. Schweizerische Medizinische Wochenschrift 118(5): 165–169, 1988 Helgeland A, Strommen R, Hagelund CH, Tretli S. Enalapril, atenolol and hydrochlorothiazide in mild to moderate hypertension. Lancet 1: 872–875, 1986 Hodsman GP, Brown JJ, Cumming AMM, Davies DL, East BW, et al. Enalapril in the treatment of hypertension with renal artery stenosis. British Medical Journal 287: 1413–1417, 1983 Holman RR, Mayon-White V, Orde-Peckar C, Steemson J, Smith B. Prevention of deterioration of renal and sensory nerve function by more intensive management of insulin-dependent diabetic patients. Lancet 1: 204–207, 1983 Hommel E, Mathiesen E, Edsberg B, Bahnsen M, Parving HH. Acute reduction of arterial blood pressure reduces urinary albumin excretion in Type I (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia 29: 211–215, 1986a Hommel E, Parving HH, Mathiesen E, Edsberg B, Damkjaer Nielsen M, et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British Medical Journal 293: 467–470, 1986b Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE. Captopril-induced,functional renal insufficiency in patients with bilateral renal-artery stenosis in a solitary kidney. New England Journal of Medicine 308: 373–377, 1983 Hutchison FN, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting-enzyme inhibition. American Journal of Physiology 253: F719–F725, 1987 Insua A, Ribstein J, Mimran A. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Postgraduate Medical Journal 64: 59–62, 1988 Jackson B, Debrevi L, Whitty M, Johnston CI. Progression of renal disease: effects of different classes of antihypertensive therapy. Journal of Hypertension 4 (Suppl. 5): 269–271, 1986 Jarrett RJ, Viberti GC. Risk of nephropathy in diabetes mellitus: problems of methodology and terminology. Diabetologia 28: 181, 1985 Keane WF, Anderson S, Aurell M, et al. Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Annals of Internal Medicine 111: 503–516, 1989 Keen H, Chlouverakis C. An immunoassay method of urinary albumin at low concentrations. Lancet 2: 913–914, 1963 Kelleher CC, Ferriss JB, Cole M, O’Sullivan DJ. Enalapril and microalbuminuria in diabetic and non-diabetic hypertension. Journal of Human Hypertension 1: 181–183, 1987 Kelleher CC, Kingston SM, Barry DG, Cole M, Ferriss JB, et al. Hypertension in diabetic clinic patients and their siblings. Diabetologia 31: 76–81, 1988 Lancaster SG, Todd PA. Lisinopril: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 35: 646–669, 1988 Marre M, Chatellier G, Leblanc H, Guyenne TT, Menard J, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. British Medical Journal 297: 1092–1095, 1988 Marre M, Leblanc H, Suarez L, Guyenne TT, Menard J, et al. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. British Medical Journal 294: 1448–1452, 1987 Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PAA, Deckert T. Incipient nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984 McMurray J, Fraser DM. Captopril, enalapril and blood glucose. Lancet 1: 1035, 1986 Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney International 31: 673–689, 1987 Murphy MB, Lewis PJ, Kohner E, et al. Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up. Lancet 2: 1293–1295, 1982 Nathan DM, Rosenbaum C, Protasowicki VD. Single void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10: 414–418, 1987 O’Hare JA, Ferriss JB, Brady D, Twomey B, O’Sullivan DJ. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 7 (Suppl. II): 43–48, 1985 O’Hare JP, Capps N, Bottomley S, Sykes J, Sewell G, et al. Low-dose captopril reduces proteinuria in diabetic nephropathy without reducing blood pressure. Diabetic Medicine 6 (Suppl. 1): A3, 1988 Parving HH, Hommel E, Damkjaer-Nielsen M, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. British Medical Journal 299: 533–536, 1989 Parving HH, Hommel E, Smidt UM. Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. British Medical Journal 297: 1086–1091, 1988 Passa PH, Marre M, Leblanc H. Treatment of arterial hypertensionin diabetics. Presse Médicale 14: 2242–2244, 1985 Roethlisberger FJ, Dixon WJ. Management and the worker, Cambridge Harvard University Press, 1946 Romanelli G, Giustina A, Cimino A, Valentini U, Agabiti-Rosei E, et al. Short-term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics. British Medical Journal 298: 284–288, 1989 Sharpe DN, Murphy J, Coxon R, Hannan SF. Enalapril in patients with chronic heart failure: a placebo-controlled, randomised, double-blind study. Circulation 70: 271–278, 1984 Sullivan PA, Kelleher M, Twomey M, Dineen M. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. Journal of Hypertension 3: 359–363, 1985 Sweet CS, Blaine EH. Angiotensin-converting enzyme inhibitors. In Van Zwieten PA (Ed.) Handbook of hypertension, Vol. 3, pp. 343–363, E sevier Science Publishers B.V., 1984 Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, et al. Effect of captopril on heavy proteinuria in azotemic diabetes. New England Journal of Medicine 313: 1617–1620, 1985 Valvo E, Bedogna V, Casagrande P, Antiga L, Zamboni M, et al. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal haemodynamic alterations. American Journal of Medicine 85: 344–348, 1988 Vasquez B, Flock EV, Savage PJ, Nagulespanian M, Bennion LJ, et al. Sustained reduction of proteinuria in Type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 26: 127–133, 1984 Viberti GC. Aetiology and prognostic significance of albuminuria in diabetes. Diabetes Care 11: 840–845, 1988 Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H. Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. British Medical Journal 286: 598–602, 1983 Viberti GC, Keen H. Patterns of proteinuria in diabetes mellitus. Diabetes 33: 686–692, 1984 Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. British Medical Journal 295: 515–520, 1987 Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril and the combination in black and white mild-to-moderate hypertensive patients. Journal of Cardiovascular Pharmacology 7 (Suppl. 1): 52–55, 1985 Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Archives of Internal Medicine 147: 830–842, 1987 Zucchelli P, Zuccala A, Sturani A. Glomerular dysfunction in diabetic nephropathy. Postgraduate Medical Journal 64 (Suppl. 3): 22–30, 1988